Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

Guest Post: Room for optimism in ALS research

March 3, 2017

We are pleased to host a Q&A with Rob Goldstein from the ALS Therapy Development Institute to discuss treating rare diseases such as ALS.

Read More

Guest Contributor: Debra of America on Epidermolysis Bullosa

March 3, 2017

Read about how Debra of America is promoting gene therapy to drive innovative treatments for rare diseases like Epidermolysis Bullosa.

Read More

Guest Post: A Cure for Ellie on Leukodystrophy-LBSL

March 2, 2017

We’re excited to share a new blog post from Beth McGinn at A Cure for Ellie, an organization founded following her daughter’s diagnosis of Leukodystrophy-LBSL

Read More

Case Study: How one online pharmacy knowingly endangered U.S. consumers

March 2, 2017

A real example of one online pharmacy that was caught selling counterfeit medicines to U.S. consumers.

Read More

Guest Post: Epilepsy Foundation on rare diseases

March 1, 2017

Epilepsy is the fourth most common neurological disorder, affecting more than 3 million Americans.

Read More

How innovative medicines are benefiting countries across the globe

March 1, 2017

Our new Prescription Medicines: International Costs in Context explains how medicines benefit patients, health care systems, and the global economy.

Read More

Why drug importation threatens patient safety

February 28, 2017

A closer look at why drug importation proposals put patient safety at risk.

Read More

Rare Disease Day: Accelerating innovation for patients in need

February 28, 2017

The biopharmaceutical industry is committed to advancing novel therapies for the more than 30 million Americans suffering from a rare disease today.

Read More

Medicare Monday: There’s an agency called MedPAC?

February 27, 2017

MedPAC is an independent congressional agency that was created by the Balanced Budget Act of 1997.

Read More

Fact Check Friday: The truth about drug importation and patient safety

February 24, 2017

We’re discussing the truth about proposals to allow the importation of medicines from other countries and what these proposals mean for patients.

Read More